# FDA recall D-1504-2014

> **Daiichi Sankyo Pharma Development** · Class II · drug recall initiated 2014-07-12.

## Product

Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg*/25 mg 30 count bottles, Rx Only  Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-116-30

## Reason for recall

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1504-2014
- **Recalling firm:** Daiichi Sankyo Pharma Development
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-07-12
- **Report date:** 2014-08-06
- **Termination date:** 2015-03-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Edison, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1504-2014

## Citation

> AI Analytics. FDA recall D-1504-2014. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1504-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*